CJC-1295 research guide for Sharpes. Covers DAC vs no-DAC forms, half-life differences, purity testing, and how to source quality CJC-1295 for research.
Unlike common nutraceuticals stocked in every health store, CJC-1295 reaches researchers through a specialist research supply market that Sharpes residents reach through online vendors. This matters because CJC-1295 quality differs enormously across the market — from verified research-grade material to products with serious contamination — and the vendor controls every quality variable. Vendors worth sourcing from openly share batch-matched Certificates of Analysis showing HPLC chromatograms, mass spec identity confirmation, endotoxin levels, and residual solvent results — all for the specific lot you are purchasing. The sections below cover what Sharpes researchers need to know about purchasing, testing, and working with CJC-1295 for scientific research use.
CJC-1295: What the Research Shows
The selectivity profile of different GHS compounds is a critical research consideration. GHRP-6 and GHRP-2 produce GH release alongside cortisol and prolactin elevation — a confounding factor in research designs where these hormones are outcome variables. Ipamorelin was specifically developed for greater GH-release selectivity with minimal cortisol and prolactin elevation, making it more suitable for research designs where GH-specific effects need to be isolated. Hexarelin has the strongest GH-releasing potency in the GHRP class but also the most significant cortisol and prolactin effects. For Sharpes researchers designing GH-axis studies, compound selection based on this selectivity profile should precede protocol finalization.
Buying CJC-1295: Quality Markers to Look For
Vetting CJC-1295 vendors requires starting from the COA: request the batch-specific certificate prior to buying, not after. A COA for CJC-1295 should include: HPLC purity percentage with the underlying chromatogram, mass spectrometry data establishing the correct molecular weight, endotoxin test results, and a residual solvent panel — all specific to the lot you receive. Warning signs in CJC-1295 vendor evaluation: prices significantly below market average, vague sourcing information, no community presence, and COAs that omit endotoxin testing. For Sharpes researchers making a first CJC-1295 purchase: verify the vendor against this framework, begin with a small order, and verify batch traceability on arrival before use.
Order CJC-1295 — ships to Sharpes
COA-verified · International tracking · Research grade
All use of CJC-1295 in Sharpes or anywhere is research use only — this compound is not approved for clinical human use, and all handling should follow research laboratory protocols. Temperature excursions — even short periods above −20°C — can partially degrade CJC-1295 without detectable changes to appearance; always verify cold chain was maintained during shipping. Bacterial endotoxin contamination is the greatest safety hazard specific to research peptides — verify endotoxin testing is documented in your batch COA before any injectable research application. The research literature on CJC-1295 should be studied thoroughly before beginning any research — study approaches, dose levels, and measured endpoints vary significantly and results do not always generalise across models.
Frequently Asked Questions
What is CJC-1295?
CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.
What purity is required for CJC-1295 research?
CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.
